Could a Preoperative Feeding Jejunostomy Decrease Sarcopenia for Patients With Oesogastric Adenocarcinoma ?

University Hospital, Strasbourg, France40 enrolled

Overview

The study of sarcopenia is a subject that is the subject of numerous research and publications, particularly because of its link with a poor prognosis for many cancers. In an article published by the digestive surgery team, the role of feeding jejunostomy has been demonstrated: it allowed more patients to reach the 2nd stage of surgery and a better tolerance of chemotherapy. Investigators wanted to study retrospectively the impact of feeding jejunostomy on radiological sarcopenia. Is the positive effect of jejunostomy in gastric cancers associated with a decrease in sarcopenia?

Study Type

OBSERVATIONAL

Enrollment

Conditions

Sarcopenia

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Criteria for inclusion: * Age 18-80 years * Sex: H or F * Subject giving their consent for their participation * Gastric cancers * stage\> IB * whether or not a feeding jejunostomy * CT scan performed at the HUS, after the end of the courses of chemotherapy and / or before the surgery. Exclusion criteria: * antecedent level L3 surgery, * psoas hematoma * No CT performed at HUS at the end of chemotherapy and / or before surgery * Impossibility of giving the subject informed information * Subject under the protection of justice * Subject under guardianship or curatorship

Locations (1)

Service Imagerie 1

Outcomes

Primary Outcomes

Evaluate muscle status by CT evaluation of sarcopenia in patients

Evaluate the impact of feeding jejunostomy in patients with gastric cancer

Time frame: 24 hour after the realization of the MRI